APA (7th ed.) Citation

Gillissen, B., Wendt, J., Richter, A., Richter, A., Müer, A., Overkamp, T., . . . Daniel, P. T. (2010). Endogenous Bak inhibitors Mcl-1 and Bcl-xL: Differential impact on TRAIL resistance in Bax-deficient carcinoma. Journal of Cell Biology, 188(6), 851. https://doi.org/10.1083/jcb.200912070

Chicago Style (17th ed.) Citation

Gillissen, Bernhard, et al. "Endogenous Bak Inhibitors Mcl-1 and Bcl-xL: Differential Impact on TRAIL Resistance in Bax-deficient Carcinoma." Journal of Cell Biology 188, no. 6 (2010): 851. https://doi.org/10.1083/jcb.200912070.

MLA (9th ed.) Citation

Gillissen, Bernhard, et al. "Endogenous Bak Inhibitors Mcl-1 and Bcl-xL: Differential Impact on TRAIL Resistance in Bax-deficient Carcinoma." Journal of Cell Biology, vol. 188, no. 6, 2010, p. 851, https://doi.org/10.1083/jcb.200912070.